Trial Profile
Prospective clinical study on efficacy and tolerability (examination of gastrointestinal symptoms) of mineral and bone disorder of Sucroferric oxyhydroxide in hemodialysis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Feb 2020
Price :
$35
*
At a glance
- Drugs Sucroferric oxyhydroxide (Primary)
- Indications Hyperphosphataemia
- Focus Therapeutic Use
- 21 Feb 2020 Status changed from active, no longer recruiting to completed.
- 10 Feb 2019 Status changed from not yet recruiting to active, no longer recruiting.
- 13 Aug 2018 New trial record